Bearish
ERAS Stock Slips As Form 144 Insider Sale Looms
Erasca Inc. (ERAS) stock has fallen by 8.64% due to negative sentiment from its oncology trial developments and, more significantly, the filing of a F...
Bearish
Erasca Inc. (ERAS) stock has fallen by 8.64% due to negative sentiment from its oncology trial developments and, more significantly, the filing of a F...